Design Therapeutics, Inc.·4

Feb 2, 7:51 PM ET

Jeffries Sean 4

4 · Design Therapeutics, Inc. · Filed Feb 2, 2022

Insider Transaction Report

Form 4
Period: 2022-02-01
Jeffries Sean
Chief Operating Officer
Transactions
  • Award

    Stock Option (right to buy)

    2022-02-01+350,000350,000 total
    Exercise: $12.77Exp: 2032-01-31Common Stock (350,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option will vest as follows: 20% of the shares will vest on February 1, 2023, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION